©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
The Saccharomyces cerevisiae RIB4 Gene Codes for 6,7-Dimethyl- 8-ribityllumazine Synthase Involved in Riboflavin Biosynthesis
MOLECULAR CHARACTERIZATION OF THE GENE AND PURIFICATION OF THE ENCODED PROTEIN (*)

(Received for publication, May 2, 1995; and in revised form, July 24, 1995)

José J. García-Ramírez (§) Maria A. Santos José L. Revuelta (¶)

From the Departamento de Microbiología y Genética, Universidad de Salamanca, 37007 Salamanca, Spain

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
ACKNOWLEDGEMENTS
REFERENCES

ABSTRACT

6,7-Dimethyl-8-ribityllumazine, the immediate biosynthetic precursor of riboflavin, is synthesized by condensation of 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione with 3,4-dihydroxy-2-butanone 4-phosphate. The gene coding for 6,7-dimethyl-8-ribityllumazine synthase in Saccharomyces cerevisiae (RIB4) has been cloned by functional complementation of a mutant accumulating 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione, which can grow on riboflavin- or diacetyl- but not on 3,4-dihydroxy-2-butanone-supplemented media. Gene disruption of the chromosomal copy of RIB4 led to riboflavin auxotrophy and loss of enzyme activity. Nucleotide sequencing revealed a 169-base pair open reading frame encoding a 18.6-kDa protein. Hybridization analysis indicated that RIB4 is a single copy gene located on the left arm of chromosome XV. Overexpression of the RIB4 coding sequence in yeast cells under the control of the strong TEF1 promoter allowed ready purification of 6,7-dimethyl-8-ribityllumazine synthase to apparent homogeneity by a simple procedure. Initial structural characterization of 6,7-dimethyl-8-ribityllumazine synthase by gel filtration chromatography and both nondenaturing pore limit and SDS-polyacrylamide gel electrophoresis showed that the enzyme forms a pentamer of identical 16.8-kDa subunits. The derived amino acid sequence of RIB4 shows extensive homology to the sequences of the beta subunits of riboflavin synthase from Bacillus subtilis and other prokaryotes.


INTRODUCTION

Riboflavin, vitamin B(2), is the precursor of flavin mononucleotide and flavin adenine dinucleotide, which function as coenzymes for a wide variety of enzymes in intermediate metabolism. Whereas lower organisms are able to biosynthesize riboflavin, mammals have lost this capacity and, therefore, rely on its dietary ingestion to meet their metabolic needs. As a consequence, this compound is commercially important as an additive in food industries, and several flavinogenic microorganisms, including some yeast species, are used in industry to produce riboflavin by fermentation(1) .

The yeast Saccharomyces cerevisiae has been thoroughly used to analyze flavinogenesis biochemically and genetically (2) and some yeast species have been developed for the biotechnological production of riboflavin(1) . Six complementation groups of S. cerevisiae riboflavin auxotrophs (rib1 to rib5 and rib7) have been identified(3, 4) . The immediate precursor of riboflavin, 6,7-dimethyl-8-ribityllumazine (see Fig. 1, 4), is formed by condensation of 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione (see Fig. 1, 3) with 3,4-dihydroxy-2-butanone 4-phosphate (see Fig. 1, 2). Two types of mutants, rib3 and rib4, have been shown to be impaired in the synthesis of the immediate precursor of riboflavin, 6,7-dimethyl-8-ribityllumazine, but they have not been correlated with specific defects in the synthesis of riboflavin. We report here that rib4 mutants are defective in 6,7-dimethyl-8-ribityllumazine synthase.


Figure 1: Biosynthesis of 6,7-dimethyl-8-ribityllumazine. 1, ribulose-5-phosphate; 2, 3,4-dihydroxy-2-butanone 4-phosphate; 3, 5amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione; 4, 6,7-dimethyl-8-ribityllumazine.




EXPERIMENTAL PROCEDURES

Materials

All reagent chemicals were of the highest commercial grade. 6,7-dimethyl-8-ribityllumazine and 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione were synthesized as described(10) . 3,4-dihydroxy-2-butanone was synthesized from acetol and formaldehyde under previously described conditions(11) . Restriction enzymes and DNA modification enzymes were from Pharmacia Biotech Inc., New England Biolabs, or Boehringer Mannheim. Thermus aquaticus DNA polymerase was from Perkin-Elmer. Oligonucleotides RIB41 (5`-AGTTTTAATTACAAAATGGCAGTTAAA-3`), RIB42 (5`-GGACAAACACAGTTGAGT-3`), RIB43 (5`-CCAACGGCCATGAATGATACCGAC-3`), Tef1 (5`-GAATTCTAGATATCAATAGTCATACAACAGAA-3`), and Tef2 (5`-CATTTTGTAATTAAAACTTGA-3`) were synthesized on an Applied Biosystems synthesizer.

Strains and Media

The following S. cerevisiae strains were used in this study. X2180-1A (MATa), and TD30 (MATalpha ura3-52 leu2-3 ino1) were obtained from F. del Rey (Universidad de Salamanca.) JC2a (MATalpha leu2, 3-112 his3-Delta1 ura3-52) and SI502B (MATaleu2, 3-112 his3-Delta1 ura3-52) were a kind gift of M. Jayaram (University of Texas). Strains YNN295 (MATalpha ura3-52 lys2 ade1 ade2 his7 trp1-Delta1) and YPH149 (MATalpha ura3-52 lys2-801 ade2-101 his7 trp1-Delta1 CFVII(RAD2.p.YPH149 (CFVII(RAD2.d.YPH146.TRP1))-) were obtained from the Yeast Genetic Stock Center (University of California). Riboflavin auxotrophs JA119 (MATarib3-1 leu2, 3-112 ura3-52), AJ21 (MATalpha rib4-1 leu2, 3-112 his3-Delta1 ura3-52), and AJ22 (MATarib4-2 leu2, 3-112 ura3-52) were derived by ethyl methanesulfonate mutagenesis from the parental strains SI502B and JC2a(12) . The rib4 deletion strain AJ106 (MATalpha rib4Delta11::URA3 leu2, 3-112 ino1 ura3-52) was constructed in strain TD30 by the one-step gene disruption method described by Rothstein(13) . General methods for the genetic manipulations of yeast cells were carried out as described previously(14) . Yeast strains auxotrophic for riboflavin, rib3 and rib4 mutants, were cultured in media with riboflavin at a concentration of 20 mg/liter.

Plasmids and Gene Deletion

The URA3 plasmid YEp13 and the genomic library made in this vector have been described earlier(15) . A rib4 deletion/substitution allele, designated rib4Delta11::URA3, was constructed by replacing the 0.5-kb (^1)PstI-SspI fragment, which contains most of the RIB4 open reading frame, with the URA3 gene. First, the 3.0-kb XbaI-PstI and 1.3-kb SspI-SalI fragments, flanking the 0.5-kb PstI-SspI fragment, were successively cloned into the XbaI and PstI site and the EcoRV and SalI site, respectively, of pBluescript KS+ (Stratagene) yielding pJR586. Finally, pJR586 was digested with EcoRI, treated with the Klenow fragment of DNA polymerase I to generate blunt ends, and ligated to a 1.1-kb blunt-ended fragment containing the URA3 gene of YEp24 (16) to generate pJR591. The linear 3.3-kb BglII-ClaI fragment of this plasmid was used for the transformation of haploid strain TD30. Ura colonies were selected, and gene deletion was confirmed by Southern blot analysis.

To construct the TEF1-RIB4 gene fusion, appropriately designed oligonucleotides and polymerase chain reactions were used. Firstly, a fragment containing the 5` region of the TEF1 gene (nucleotides -635 to 3) (17) was amplified using oligonucleotides Tef1 and Tef2 and genomic DNA from strain X2180-1A as template. Secondly, another fragment containing nucleotides -18 to 3 of TEF1 joined to the coding and terminator sequences of RIB4 (nucleotides 3-726) was amplified using oligonucleotides RIB41 and RIB42 and DNA of pJR633 as template. Finally, the two partially overlapping fragments generated in the two previous reactions were joined by polymerase chain reaction in a contiguous fragment (containing nucleotides -635 to -1 of TEF1 fused to nucleotides 1-726 of RIB4) using oligonucleotides Tef1 and RIB42 and the two previously amplified fragments as templates. The resulting fragment was verified by sequencing and cloned into YEp352 to yield pJR627.

Nucleic Acid Manipulations

Transformation of Escherichia coli, Southern blot analysis and other routine DNA and RNA manipulations were carried out as described by Sambrook et al.(18) . Yeast cells were transformed by the method of Ito et al.(19) . Plasmids were recovered from yeast cells by the rapid protocol described previously(20) .

DNA sequencing reactions were performed using the dideoxy chain reaction (21) using the T7 sequencing system (Pharmacia). Primer extension analyses were done as described (18) using the synthetic oligonucleotide RIB43, which is complementary to nucleotides 57-80 of the RIB4 ORF.

6,7-Dimethyl-8-ribityllumazine Synthase Purification and Enzyme Assay

AJ106 yeast cells transformed with pJR627 were grown to late-log phase (A = 1.5-2) in SD medium lacking riboflavin to select plasmid-containing cells. All procedures described below were done at 4 °C unless otherwise stated. Cells were harvested by centrifugation, washed once with ice-cold water, and resuspended in 1/50 volume of extraction buffer (20 mM Tris-HCl, pH 7.5, containing 1 mM phenylmethylsulfonyl fluoride). Glass beads (0.5 mm) were added, and the cells were disrupted in a Braun homogenizer. Glass beads, unbroken cells and cell wall components were removed by centrifugation at 4000 times g for 20 min. The crude extract was then centrifuged at 100,000 times g for 60 min to obtain the supernatant cytosolic fraction. Methyl alcohol (final concentration, 30%, v/v) was added to the cytosolic fraction, incubated at 0 °C for 12 h and centrifuged at 15,000 times g for 60 min. The supernatant fraction was then lyophilized, resuspended in 20 mM Tris-HCl, pH 7.5, and passed through a 0.45-µm sterile filter prior to the ion exchange chromatographic step. In consecutive runs, the filtered protein fraction (5 mg/ml) was loaded onto a MonoQ column (0.5 times 5-cm, HR 5/5, fast performance liquid chromatography system, Pharmacia) that had been equilibrated with 20 mM Tris-HCl, pH 7.5. After sample passage, the column was washed with 5 ml of the same buffer, and the chromatogram was developed with a 25-ml linear gradient of 0.05-0.5 M NaCl in 20 mM Tris-HCl, pH 7.5. Fractions (0.5 ml) were analyzed by SDS-PAGE and enzyme activity. Lumazine synthase eluted at about 300 mM NaCl in the gradient. Fractions from MonoQ chromatographies containing enzyme activity were pooled, concentrated by lyophilization, resuspended in 20 mM Tris-HCl, pH 7.5, and loaded onto a SuperDex 200 column (Pharmacia) that had been equilibrated with 20 mM Tris-HCl, pH 7.5, 90 mM NaCl. Peak fractions (0.25 ml, fractions 28-30) for lumazine synthase activity eluted from the SuperDex 200 chromatography appeared apparently pure as judged by SDS-PAGE analysis. Lumazine synthase activity was determined by the procedure described by Neuberger and Bacher(22) . Enzyme activity is expressed as nanomoles of 6,7-dimethly-8-ribityllumazine formed per h.

Other Protein Methods

The method of Laemmli (23) was used for SDS-PAGE, and proteins were detected by silver staining. Protein content was determined by the method of Lowry et al.(24) The apparent native molecular mass of purified riboflavin synthase was determined by both gel filtration chromatography and nondenaturing pore limit PAGE. Nondenaturing pore limit PAGE was done as described previously (25) on a 4-20% polyacrylamide gradient gel (Bio-Rad).

Computer-aided Analysis of Sequence Data

The search for protein homologies was performed through the National Center for Biotechnology Information using the BLAST network service. Alignments of amino acid sequences were performed with a number of computer programs including the CLUSTAL algorithm(26) .


RESULTS

Characterization of rib3 and rib4 Mutants

rib3 and rib4 mutants of S. cerevisiae are phenotypically indistinguishable and accumulate the same blue-fluorescent intermediate compound 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione (3) . Because the accumulated pyrimidine is the biosynthetic precursor of 6,7-dimethyl-8-ribityllumazine and both types of mutants are able to grow on media supplemented with riboflavin or diacetyl (diacetyl condenses nonenzymatically with 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione to yield 6,7-dimethyl-8-ribityllumazine), it was assumed that both types of mutants were affected in the synthesis of 6,7-dimethyl-8-ribityllumazine. Two enzymes (3, 4-dihydroxy-2-butanone 4-phosphate synthase and 6, 7-dimethyl-8-ribityllumazine synthase) are required for the enzymatic conversion of 5-amino-6-ribitylamino-2,4(1H,3H)-pyrimidinedione to 6,7-dimethyl-8-ribityllumazine (Fig. 1). In order to determine which specific metabolic step was affected in rib3 and rib4 mutants, we developed a nutritional test using chemically synthesized 3,4-dihydroxy-2-butanone. This compound is identical to the product of the reaction catalyzed by synthase (3, 4-dihydroxy-2-butanone 4-phosphate), except that it lacks the phosphate group. Because this phosphate is eliminated prior to or during the subsequent condensation reaction, we expected that the addition of the dephosphorylated compound to the media would allow growth of the mutants affected in 3,4-dihydroxy-2-butanone 4-phosphate synthase but not of the mutants lacking 6,7-dimethyl-8-ribityllumazine synthase. The addition of 3,4-dihydroxy-2-butanone was not toxic for the yeast cells as demonstrated by the same density of growth shown by wild-type X2180-1A cells on plates containing the different concentrations of 3,4-dihydroxy-2-butanone assayed (0-400 µg/ml) (Table 1). Whereas the addition of riboflavin or diacetyl supported the growth of both JA119 (rib3-1) and AJ21 (rib4-1) mutant cells, only rib3 cells grew on 3,4-dihydroxy-2-butanone-supplemented minimal medium. This result indicates that rib3 mutants are blocked prior to and rib4 mutants are blocked after the synthesis of 3,4-dihydroxy-2-butanone or its phosphorylated derivative. Thus, according to the order of the reactions depicted in Fig. 1, RIB3 should encode 3,4-dihydroxy-2-butanone 4-phosphate synthase, and RIB4 should encode 6,7-dimethyl-8-ribityllumazine synthase. We have cloned the RIB3 and RIB4 genes by functional complementation of their respective mutations. In this paper we describe the isolation and characterization of RIB4 and the purification and preliminary analysis of the encoded protein.



Cloning of RIB4

The RIB4 gene was isolated by complementation of the riboflavin auxotrophy of the rib4-1 mutant strain AJ21. This strain was transformed with a yeast genomic DNA library constructed in the yeast shuttle vector YEp13(15) . One of the complementing plasmids, designated pJR66, was chosen for further analyses. A series of subclones of pJR66 were constructed into vector YEp352 to delineate the end points of the RIB4 gene (Fig. 2A). One of these subclones, pJR497, contained a 4.2-kb BglII-XbaI fragment that complemented the rib4 mutation of AJ21. When a 2.1-kb HpaI-XbaI fragment was removed from pJR497 to generate pJR633, the smallest subclone complementing the rib4 auxotrophy was generated. Comparison of the restriction maps of pJR633 and pJR609, the latter of which does not complement the mutation, indicates that the RIB4 gene should span a cluster of BamHI, HindIII, SalI, ClaI, and PstI restriction sites.


Figure 2: Characterization and deletion of the RIB4 locus. A, restriction map of the isolated 6.6-kb fragment and complementation analysis of different subclones in the multicopy plasmid YEp352. Plus and minus signs indicate whether this fragment complements (+) or does not complement(-) the riboflavin auxotrophy of strain AJ21 (rib4-1). B, RIB4 gene deletion. A 0.5-kb SspI-PstI fragment encompassing most of the RIB4 ORF was replaced by a 1.1-kb URA3 gene (left). Genomic DNA was extracted from wild-type (TD30) and deleted rib4Delta11::URA3 mutant (AJ106) strains and digested with ClaI. The digestion products were separated on a 1% agarose gel, transferred to a nylon membrane, and probed with a P-labeled, 1.5-kb ClaI fragment (right).



Based on the phenotype of the rib4-1 mutation, disruption of the RIB4 locus was not expected to be lethal but should result in riboflavin auxotrophy. To inactivate RIB4 function, the RIB4 gene of the haploid, wild-type TD30 strain was disrupted by the one-step gene disruption method(13) . A deletion/substitution of the 0.5-kb SspI-PstI fragment, spanning the cluster of restriction sites, by a 1.1-kb fragment containing the URA3 gene was created as described under ``Experimental Procedures'' (Fig. 2B). Uracil prototroph (Ura) transformants were riboflavin auxotrophs (Rib) as determined by replica-plating onto complete media lacking riboflavin. Moreover, these transformants showed the rib4 phenotype (i.e. accumulation of 5-amino-6-ribitylamino-2, 4(1H,3H)-pyrimidinedione and the ability to grow on diacetyl but not on 3,4-dihydroxy-2-butanone-supplemented minimal medium). A Southern hybridization analysis of genomic DNA of the parental strain TD30 and one Rib Ura transformant, designated AJ106 (rib4Delta11::URA3), were used to confirm genomic integration and deletion at the correct site (Fig. 2B). Strain AJ106 was crossed with strain AJ22; the resulting diploid had an Rib phenotype, suggesting that the two mutations are allelic. Finally, the diploid was sporulated, and 15 tetrads were dissected. As expected, all tetrads analyzed segregated four Rib spores, showing the identity of the cloned gene and RIB4.

Nucleotide Sequence Analysis of RIB4

The nucleotide sequence of the 2.1-kb BglII-HpaI fragment of pJR633 was determined on both strands. The sequence contains a single complete open reading frame, capable of encoding a protein of 169 amino acids with a calculated molecular mass of 18.6 kDa (Fig. 3). An in-frame stop codon is located 9 base pairs upstream from the putative initiating methionine codon. The yeast intron splice signal TACTAAC (27) was not found. The upstream flanking region of the RIB4 open reading frame reveals the presence of a conserved TATA-box sequence (28, 29) at position -105 with respect to the ATG initiation codon. A striking feature of the upstream region is the repeated decanucleotide AGTATAACGC, which occurs in a perfect tandem repeat of four copies immediately preceding the initiation codon. At the 3` end of the gene, the open reading frame is terminated by two consecutive stop codons. Consensus sequences for polyadenylation, ATATAT(30) , and transcription termination in yeast, TGA(n)TATGT(n)TTT(31) , were detected at positions 508 and 532, respectively.


Figure 3: Nucleotide sequence and predicted amino acid sequence of the RIB4 gene. Amino acids are shown in three-letter codes. The numbering adopted for both nucleotides and amino acids is initiated at the first ATG of the RIB4 ORF. The consensus TATA element is underlined, and the four repeats are underlined with arrows. Two downwardarrowheads indicate the major transcription initiation sites. In the 3`-flanking region, sequences matching the transcription termination and polyadenylation signals are indicated by open circles and filled circles, respectively.



The predicted encoded product is a slightly charged protein with a calculated pI of 6.61. Hydropathy analysis (32, 33) predicts a moderately hydrophilic, globular protein with no sequence of sufficient length and hydrophobicity to be considered a membrane-spanning domain. From the distribution of the codons used, a codon adaptation index of 0.271 can be calculated(34) , which suggests a weak or moderate level of gene expression.

Direct evidence for the expression of the RIB4 open reading frame came from Northern blot analysis of S. cerevisiae mRNA using the 0.3-kb BamHI-PstI containing part of RIB4 as a probe. In the experiments of Fig. 4A, mRNA transcripts of the anticipated size for RIB4, approximately 700 nucleotides, were readily detected even in the presence of saturating concentrations of riboflavin in the culture medium, suggesting that the endogenous RIB4 gene is constitutively expressed in yeast. We have also determined the initiation sites for RIB4 transcription by primer extension analyses (Fig. 4B). Two major initiation sites occur roughly 60 nucleotides downstream from the TATA box-like sequence CATATAAA and therefore occur well within the region predicted for a S. cerevisiae TATA box(35, 36, 37) .


Figure 4: Analysis of the RIB4 transcript. A, Northern analysis. Total RNA (50 µg) from wild-type strain X2180-1A grown on different culture media was purified, electrophoresed, transferred to a nylon membrane, and probed with a P-labeled fragment containing part of the RIB4 ORF. Lane 1, minimal medium; lane 2, minimal medium supplemented with 200 µg/ml riboflavin; lane 3, rich medium supplemented with 200 µg/ml riboflavin. The ACT1 transcripts serve as an internal control. B, Primer extension analysis. A synthetic 24-mer oligonucleotide (RIB43), complementary to nucleotides 57-80 of the RIB4 ORF, was annealed to 25 µg of poly(A) RNA from the wild-type strain X2180-1A (lane 1) or 25 µg of yeast tRNA (lane 2) and extended with avian myeloblastosis virus reverse transcriptase. The extension products were run on a denaturing polyacrylamide gel next to a sequencing reaction using the same oligonucleotide as sequencing primer. The positions of the major extension products are indicated on the right.



Physical Mapping of RIB4

In order to determine the chromosomal location of RIB4, the 2.1-kb BglII-HpaI fragment from pJR633 was used as a probe to hybridize to yeast chromosomes from the strain YNN295 that had been separated by pulse-field gel electrophoresis. A signal was detected at the position of the comigrating chromosomes VII and XV. The experiment was therefore repeated with chromosomes from strain YPH149, in which chromosome XV is clearly separated by gel electrophoresis from two small chromosomal fragments derived from chromosome VII. In this case, the RIB4 probe hybridized only to chromosome XV (data not shown). A more precise physical location of RIB4 was determined by hybridization of the RIB4 probe to a set of overlapping and cosmid clones representing 96% of the S. cerevisiae genome (American Type Culture Collection 76269; (38) ). The RIB4 probe only hybridized to ATCC clone 70642, which posseses a genomic insert from the left arm of chromosome XV. The probe did not hybridize to flanking, partially overlapping clones 70573 and 70589; thus, according to the EcoRI+HindIII restriction map provided by ATCC for these clones, the location of the RIB4 gene is delimited to a 6.1-kb EcoRI-HindIII fragment near (roughly 50-kb apart) the left telomere of chromosome XV.

Lumazine Synthase Activity of rib4 Mutants and Transformant Strains

Because accumulation and nutritional tests suggested that RIB4 encodes a structural component of 6,7-dimethyl-8-ribityllumazine synthase, we tested the in vitro activity of lumazine synthase in wild-type and rib4 strains. Although the wild-type strain X2180-1A and the parental strain TD30 showed comparable levels of lumazine synthase specific activity, almost at the limit of the detection level, none of the mutant strains, AJ21 (rib4-1), AJ22 (rib4-2), and AJ106 (rib4Delta11::URA3), showed detectable activity. Furthermore, lumazine synthase activity was restored to about 30 times higher than that of the wild-type level in rib4Delta11::URA3 mutants transformed with a 2 µm-based high copy number plasmid harboring the RIB4 gene (pJR497). To further increase the lumazine synthase-specific activity of yeast cells, a gene fusion was constructed between the 635-base pair upstream promoter sequence of the highly expressed TEF1 gene, which encodes the translation elongation factor EF-1alpha(19, 39) , and the complete coding and terminator sequences of RIB4 (see ``Experimental Procedures''). A 2.3-kb XbaI-XbaI fragment bearing the TEF1-RIB4 gene fusion was cloned into the multicopy plasmid YEp352 to generate pJR627. Yeast strain AJ106 was transformed with the recombinant plasmid pJR627 to uracil prototrophy, and lumazine synthase activity was determined. Compared with wild-type cells, disrupted rib4 cells carrying plasmid pJR627 showed an approximately 90-fold increase in lumazine synthase activity. These data indicate that the RIB4 gene encodes lumazine synthase. Furthermore, overexpression of lumazine synthase in yeast was associated with a moderate increase (2.1-fold) in the amount of free riboflavin accumulated by the cells.

Purification and Subunit Structure of Lumazine Synthase

To facilitate the purification of lumazine synthase, the protein was overproduced in yeast cells transformed with the TEF1-RIB4 gene fusion containing plasmid pJR627. The specific activity of lumazine synthase in the total cell lysate of strain TD30 transformed with pJR627 was 126 units/mg of protein, as compared with 1.35 units/mg of protein in the nontransformed TD30 strain. The procedure to generate highly purified lumazine synthase is summarized in Table 2. The protein patterns in SDS-polyacrylamide gels of the crude extract and eluated fractions containing lumazine synthase activity from the successive purification steps are depicted in Fig. 5. In SDS gels after the MonoQ step, the purified protein displayed only one major polypeptide band (Fig. 5, lane Q). Some faint bands of higher molecular masses could be removed by chromatography on a SuperDex 200 column (Fig. 5, lane S). From the total cell lysate, an approximately 120-fold enrichment was achieved with a yield of about 4% (Table 2). The final preparation had a specific activity of 8.09 mmol/h/mg and was used as the source of enzyme for further structural studies. Analysis of the purified lumazine synthase in SDS-polyacrylamide gels revealed a single protein band with an apparent molecular mass of 18 kDa (Fig. 5, lane S), which is in good agreement with the predicted molecular mass of Rib4p deduced from its amino acid composition.




Figure 5: SDS-PAGE analysis of fractions collected during purification of lumazine synthase. Proteins were resolved on 14% SDS-polyacrylamide gels and were visualized by silver staining. Molecular masses of standards (kDa) are indicated on the left. The position of Rib4p is marked with an arrow. T, total cell lysate; M, 50% methanol-soluble fraction; Q, MonoQ; S, SuperDex 200.



Two methods were used to estimate the native subunit structure of lumazine synthase (Fig. 6). Gel filtration chromatography indicated that the molecular mass of the native protein was 95 kDa using a column calibrated with typical globular proteins (Fig. 6A). Nondenaturing pore limit polyacrylamide gels were used to verify the molecular mass determined by gel filtration chromatography. The migration of lumazine synthase in 4-20% gradient nondenaturing polyacrylamide gel compared with the position of standards proteins indicated a molecular mass of 91 kDa (Fig. 6B). Based on these two results, we concluded that lumazine synthase was a homopentamer.


Figure 6: Characterization of native riboflavin synthase. A, SuperDex 200 filtration of riboflavin synthase, with thyroglobulin (a), ferritin (b), catalase (c), lactate dehydrogenase (d), bovine serum albumin (e), ovalbumin (f), carbonic anhydrase (g), and alpha-lactalbumin (h) as inclusive standards. The calculated value for lumazine synthase was 95. B, relative migration of native lumazine synthase in nondenaturing polyacrylamide (4-20%) gradient gel. Standard proteins used as markers are shown in the illustration with lumazine synthase M(r) estimated as 91. Inset, lane 1, markers; lane 2, purified lumazine synthase.



Alignment with beta Subunits of Riboflavin Synthase from Prokaryotes

Comparison of the deduced primary amino acid sequence of Rib4p with available data bases showed that Rib4p is distantly related to the beta subunits of riboflavin synthase from Bacillus subtilis (ribH), E. coli (ribH), and Photobacterium leiognathi (ribH)(7) , as shown in Fig. 7. Pairwise comparisons among these sequences revealed that the yeast Rib4p is the most highly divergent protein, displaying approximately 26-29% amino acid sequence identity to bacterial beta subunits, compared with 48-64% identities between the bacterial proteins. Analysis of these data indicated that three regions of these enzymes were most conserved. In the first region (residues 22-65 of the yeast lumazine synthase), there was a 34-46% sequence identity, which was extended to 78-82% similarity when conserved amino acids were included, to residues 15-62 of the E. coli enzyme and residues 14-61 and 15-61 of the P. leiognathi and B. subtilis enzymes, respectively. In the second region (amino acid residues 83-97 of the S. cerevisiae enzyme), 93.7% of the amino acid residues were similar and 44% were identical for all four enzymes. Moreover, in this region the yeast protein displays a marked similarity with the proposed donator, C-terminal domain of yeast riboflavin synthase(40) . Finally, in the third region (amino acid residues 120-139 of the yeast enzyme) 55% of the amino acids were identical and 80% were similar for all four proteins.


Figure 7: Sequence comparison among lumazine synthases from S. cerevisiae, E. coli, P. leiognathi, and B. subtilis. The amino acid sequence of yeast lumazine synthase was aligned to the sequences from E. coli, P. leiognathi, and B. subtilis. Amino acids identical in at least two sequences are boxed and highlighted by a gray shaded background. Amino acids identical in all four sequences are boxed and highlighted by a black background.




DISCUSSION

In this report we describe the isolation, sequence, and expression of a S. cerevisiae gene, RIB4, which encodes lumazine synthase. Nutritional tests using chemically synthesized 3,4-dihydroxy-2-butanone suggested that rib4 mutants would be defective in lumazine synthase, whereas rib3 mutants would be affected in 3,4-dihydroxy-2-butanone synthase. The fact that the 4-carbon unit 3,4-dihydroxy-2-butanone supported the growth of rib3 mutants implies that in vivo this compound is converted into a biologically active precursor molecule of riboflavin, thus compensating for the absence of the 3,4-dihydroxy-2-butanone synthase activity of these mutants. However, the nonphosphorylated form of the 4-carbon unit cannot be used as a substrate in vitro by lumazine synthase (data not shown). Thus, 3,4-dihydroxy-2-butanone must be phosphorylated in vivo in the rib3 mutant yeast cells prior its use as substrate by lumazine synthase.

Analysis of RIB4 transcript levels under different culture conditions indicates that RIB4 is constitutively expressed at moderate levels. Overexpression of the gene resulted in an approximately 90-fold increase in lumazine synthase activity but only in a slight stimulatory effect on the accumulation of free riboflavin in the cells. This suggests that lumazine synthase is not a limiting step in the metabolic flux of riboflavin formation in yeast.

Since the data presented here were obtained, we have developed a simple method of purification of Rib4p that relies on RIB4 overexpression in yeast cells by using a multicopy plasmid and placing the RIB4 coding sequence under the control of the TEF strong promoter. With this approach we were able to purify the enzyme to apparent homogeneity using a three-step purification protocol that achieves an overall purification of 120-fold with a recovery of about 4%. From comparison of either the elution volume or the R(F) of pure native lumazine synthase with those of standard proteins by gel filtration analysis or nondenaturing pore limit PAGE, respectively, a molecular mass of approximately 90,000 daltons was estimated for the native enzyme. However, an apparent subunit molecular mass of 24,500 daltons was obtained for the pure protein by SDS-PAGE analysis, in good agreement with the predicted molecular mass of Rib4p based on its deduced amino acid composition. These findings indicate that the native lumazine synthase of S. cerevisiae exists in the pentamer form of identical subunits.

Riboflavin synthase appears in B. subtilis as two different species characterized by their subunit composition. The so-called light enzyme is a trimer of alpha identical subunits of riboflavin synthase. The heavy enzyme, characterized by a molecular mass of 1 MDa, consists of an alpha subunit trimer enclosed within an icosahedral structure composed of 60 beta subunits of 6,7-dimethyl-8-ribityllumazine synthase(5, 6, 8, 41) .

The complete sequence of the B. subtilis beta subunit was first established by direct sequencing of the protein(42) . Subsequently, the amino acid sequence of lumazine synthase was confirmed by sequencing the ribH open reading frame of the B. subtilis riboflavin operon(43) . A computer prediction of the secondary structure indicated the presence of approximately 34% alpha helix, 30% beta sheet, and 18% beta turn in the beta subunit. Most alpha helices and beta strands predicted by a modified Chou-Fasman/Robson algorithm (44) in yeast lumazine synthase (data not shown) match the observed secondary elements in the Bacillus enzyme surprisingly well, thus suggesting a similar chain folding for the enzyme in both organisms. However, completely different quaternary structures, pentamers in yeast and icosahedral capsids in Bacillus, are formed.

The atomic structure of the Bacillus beta subunit has been deduced from electron density maps to 3.3 Å resolution by the group of Bacher(9) . The main chain of the beta subunit folds into a structure of four parallel beta-sheet flanked on both sides by two alpha-helical segments. Due to the symmetry relations occurring in the beta-60 icosahedral capsid, intersubunit contacts are those of dimers, trimers, and pentamers. In this context, it should be noted that most amino acid residues contributing to the stability of pentamers in the Bacillus lumazine synthase (Met^1, Ile, Arg, Met, Val, Pro, Phe, Glu, Arg, Tyr, Lys, Pro, Gln, and Thr) are conserved in the yeast enzyme. By contrast, a large proportion of amino acids involved in dimer (Arg, His, Gln^5, Asp, and Val^9) or trimer (Asp, Lys, Asp, Glu, Phe, Phe, and Thr) contacts in the icosahedral Bacillus enzyme are not conserved in yeast. Therefore, it is tempting to speculate that the discrepancy in the quaternary structures shown by the Bacillus and yeast enzymes are the result of different levels of complexity in the same pathway of protein assembly, the pentamer form corresponding to an intermediate level and the beta-60 icosahedral enzyme being the most complex stage of organization. Finally, it is assumed that in Bacillus the His may take part in the catalytic reaction as a proton-abstracting base. In agreement with this assumption, this residue is conserved in all four organisms considered.


FOOTNOTES

*
This research was supported by funds from the BASF Aktiengesellschaft and by Grant BIO92-0036 from the Comisión Interministerial de Ciencia y Tecnología, Spain. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The nucleotide sequence(s) reported in this paper has been submitted to the GenBank(TM)/EMBL Data Bank with accession number(s) Z21620[GenBank].

§
Supported by a fellowship granted by the Ministerio de Educación y Ciencia, Spain.

To whom correspondence should be addressed: Tel.: 34-23-294671; Fax: 34-23-267970.

(^1)
The abbreviations used are: kb, kilobases(s); lumazine synthase, 6,7-dimethyl-8-ribityllumazine synthase; ORF, open reading frame; PAGE, polyacrylamide gel electrophoresis; Rib4p, RIB4 encoded protein.


ACKNOWLEDGEMENTS

We thank Fernando Díez for technical help and N. Skinner for correcting the manuscript.


REFERENCES

  1. Demain, A. L. (1972) Annu. Rev. Microbiol. 26,369-388 [Medline] [Order article via Infotrieve]
  2. Bacher, A. (1991) in Chemistry and Biochemistry of Flavoproteins (Muller, F., ed) Vol. 1, pp. 215-259, Chemical Rubber Co., Boca Raton, FL
  3. Oltmanns, O., Bacher, A., Lingens, F., and Zimmermann, F. K. (1969) Mol. & Gen. Genet. 105,306-313
  4. Oltmanns, O., and Bacher, A. (1972) J. Bacteriol. 110,818-822 [Medline] [Order article via Infotrieve]
  5. Bacher, A., Baur, R., Eggers, U., Harders, H.-D., Otto, M. K., and Schnepple, H. (1980) J. Biol. Chem. 255,632-637 [Abstract/Free Full Text]
  6. Ludwig, H. C., Lottspeich, F., Henschen, A., Ladenstein, R., and Bacher, A. (1984) in Flavins and Flavoproteins (Bray, R. C., Engel, P. C., and Mayhew, S. G., eds) pp. 379-382, Walter de Gruyter, Berlin
  7. Lee, C. Y., and Meighen, E. A. (1992) Biochem. Biophys. Res. Commun. 186,690-697 [Medline] [Order article via Infotrieve]
  8. Ladenstein, R., Ludwig, H. C., and Bacher, A. (1983) J. Biol. Chem. 258,11981-11983 [Abstract/Free Full Text]
  9. Ladenstein, R., Schneider, M., Huber, R., Bartunik, H. D., Wilson, K., Schott, K., and Bacher, A. (1988) J. Mol. Biol. 203,1045-1070 [Medline] [Order article via Infotrieve]
  10. Plaut, G. W. E., and Harvey, R. A. (1971) Methods Enzymol. 18,515-538
  11. Fischer, H. O. L., Baer, E., Pollock, H., and Nidecker, H. (1937) Helv. Chim. Acta 20,1213
  12. Lawrence, C. W. (1991) Methods Enzymol. 194,273-281 [Medline] [Order article via Infotrieve]
  13. Rothstein, R. (1983) Methods Enzymol. 101,202-211 [Medline] [Order article via Infotrieve]
  14. Sherman, F., Fink, G. R., and Hicks, J. B. (1986) Methods in Yeast Genetics , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  15. Nasmyth, K. A., and Tatchell, K. (1980) Cell 19,753-764 [Medline] [Order article via Infotrieve]
  16. Botstein, D., Falco, S. C., Stewart, S. E., Brennan, M., Scherer, S., Stinchcomb, D. T., Struhl, K., and Davis, R. W. (1979) Gene (Amst.) 8,17-24 [CrossRef][Medline] [Order article via Infotrieve]
  17. Nagata, S., Nagashima, K., Tsunetsugu-Yokota, Y., Fujimura, K., Miyazaki, M., and Kaziro, Y. (1984) EMBO J. 3,1825-1830 [Abstract]
  18. Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual , Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
  19. Ito, H., Fukuda, Y., Murata, K., and Kimura, A. (1983) J. Bacteriol. 153,163-168 [Medline] [Order article via Infotrieve]
  20. Hoffman, C. S., and Winston, F. (1987) Gene (Amst.) 57,267-272 [CrossRef][Medline] [Order article via Infotrieve]
  21. Sanger, F., Nicklen, S., and Coulson, A. R. (1977) Proc. Natl. Acad. Sci. U. S. A. 74,5463-5467 [Abstract]
  22. Neuberger, G., and Bacher, A. (1986) Biochem. Biophys. Res. Commun. 139,1111-1116 [Medline] [Order article via Infotrieve]
  23. Laemmli, U. K. (1970) Nature 227,680-685 [Medline] [Order article via Infotrieve]
  24. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193,265-275 [Free Full Text]
  25. Anderson, L. O., Borg, H., and Mikaelsson, M. (1972) FEBS Lett. 20,199-201 [CrossRef][Medline] [Order article via Infotrieve]
  26. Higgins, D. G., and Sharp, P. M. (1988) Gene (Amst.) 73,237-244 [CrossRef][Medline] [Order article via Infotrieve]
  27. Langford, C. J., Klintz, F. J., Donath, C., and Gallwith, D. (1984) Cell 36,645-653 [Medline] [Order article via Infotrieve]
  28. Chen, W., and Struhl, K. (1988) Proc. Natl. Acad. Sci. U. S. A. 85,2691-2695 [Abstract]
  29. Harbury, P. A. B., and Struhl, K. (1989) Mol. Cell. Biol. 9,5298-5304 [Medline] [Order article via Infotrieve]
  30. Osborne, B. I., and Guarente, L. (1989) Proc. Natl. Acad. Sci. U. S. A. 86,4097-4101 [Abstract]
  31. Zaret, K. S., and Sherman, F. (1982) Cell 28,563-573 [Medline] [Order article via Infotrieve]
  32. Kyte, J., and Doolittle, R. F. (1982) J. Mol. Biol. 157,105-132 [Medline] [Order article via Infotrieve]
  33. Eisenberg, D., Schwarz, E., Komaromy, M., and Wall, R. (1984) J. Mol. Biol. 179,125-142 [Medline] [Order article via Infotrieve]
  34. Sharp, P. M., and Cowe, E. (1991) Yeast 7,657-678 [Medline] [Order article via Infotrieve]
  35. Chen, W., and Struhl, K. (1985) EMBO J. 4,3273-3280 [Abstract]
  36. Nagawa, F., and Fink, G. (1985) Proc. Natl. Acad. Sci. U. S. A. 82,8557-8561 [Abstract]
  37. Hahn, S., Hoar, E., and Guarente, L. (1985) Proc. Natl. Acad. Sci. U. S. A. 82,8562-8566 [Abstract]
  38. Olson, M. V., Dutchik, J. E., Graham, M. Y., Brodeur, G. M., Helms, C., Frank, M., MacCollin, M., Scheinman, R., and Frank, T. (1986) Proc. Natl. Acad. Sci. U. S. A. 83,7826-7830 [Abstract]
  39. Schirmaier, F., and Philippsen, P. (1984) EMBO J. 3,3311-3315 [Abstract]
  40. Santos, M. A., García-Ramírez, J. J., and Revuelta, J. L. (1995) J. Biol. Chem. 270,437-444 [Abstract/Free Full Text]
  41. Bacher, A., Ludwig, H. C., Schnepple, H., and Ben-Shaul, Y. (1986) J. Mol. Biol. 187,75-86 [Medline] [Order article via Infotrieve]
  42. Ludwig, H. C., Lottspeich, F., Henschen, A., Ladenstein, R., and Bacher, A. (1987) J. Biol. Chem. 262,1016-1021 [Abstract/Free Full Text]
  43. Mironov, V. N., Kraev, A. S., Chernov, B. K., Ulianov, A. V., Golova, Y. B., Pozmogova, G. E., Simonova, M. L., Gordeev, V. K., Stepanov, A. I., and Skryabin, K. G. (1989) Dokl. Akad. Nauk SSSR 305,482-487 [Medline] [Order article via Infotrieve]
  44. Nishikawa, K. (1983) Biochim. Biophys. Acta 748,285-299 [Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.